Alphabetically   > P   > Proximagen Neuroscience plc  

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
 

Proximagen Neuroscience plc

transparent spacer
transparent spacer
transparent spacer

Company Information

Address:

Hodgkin Building
Guy's Campus
King's College London
London
SE1 1UL

Tel:

+44(0)207.848.6034

Fax:

+44(0)207.848.6034

E-Mail:

info@proximagen.com

Secretary:

James Hunter

Registrar:

Capita Registrars Beckenham Ltd

Company Overview

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease.

Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic candidates, and through the identification and licensing of existing drugs for new indications.

Annual Reports

Description Report Date Published
Annual Report 2009 in PDF * 30/11/2009 31/03/2010
Annual Report 2008 in PDF 30/11/2008 23/03/2009
Annual Report 2007 in PDF 30/11/2007 3/04/2008
Annual Report 2006 in PDF 30/11/2006 27/02/2007
Annual Report 2005 in PDF (0.98Mb) 30/11/2005 26/05/2006

Interim Reports

Description Report Date Published
Interim Results 2009 in PDF * 31/05/2009 23/07/2009
Interim Results 2008 in PDF 31/05/2008 13/08/2008
Interim Results 2007 31/05/2007 29/08/2007
Interim Results 2006 31/05/2006 19/07/2006
 
Other Links
Description
bullet point Home
bullet point Investor Relations
bullet point Press Releases
bullet point Contacts

Dividend History

Type Payment Date Dividend
Nil 9/05/2006 0 p
A B C D E F G H I J K L M
N O P Q R S T U V W X Y Z